ArticleAnalytical science advances2026
A New Kinetic-Mechanistic Approach Towards Spectrophotometric Bioanalysis of 2-Phenylethylamine as a Sympathomimetic Agent Using Sodium Isopropyl Xanthate.
Article in Analytical science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
2-Phenylethylamine (2-PEA), an aromatic biogenic amine, demonstrates significant physiological and toxicological effects on human health. A variety of conventional methods have been widely used for the determination of 2-PEA. However, the necessity of complex sample preparation and high cost of instrumentation may pose challenges to their widespread application. The application of sodium isopropyl xanthate (SIPX) in spectrophotometric method was introduced a novel optical probe for simple, fast and cost-effective detection of 2-PEA. The distinct UV-Vis spectrum of SIPX is changed in the presence of the target molecule (2-PEA) which confirmed successful application of sensing strategy. Under optimal conditions, a linear range were achieved between 0.4 and 50 mM. The developed probe was characterized by dynamic light scattering (DLS) and zeta potential tests. The selectivity of prepared probe was validated by its minimal effects towards aliphatic amines, including histamine, cadaverine, 1,4-diaminobutane, spermidine and ethylenediamine. Furthermore, the validation of reported analytical approach was examined in real human plasma. It can be deduced that SIPX as a novel optical probe could offer suitable, reliable, affordable and rapid sensing platform for detection of 2-PEA in real samples. This study introduced significant innovations, including the development of a new organic optical probe for biogenic amine recognition in real samples, the establishment of a simple and rapid analytical workflow and the presentation of a novel spectrophotometric sensing platform offering selective detection of 2-PEA. These advancements highlight clear technical benefits of this opto-sensors for the specific recognition of biogenic amines compared with conventional analytical methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.